DK0531419T3 - Bistriazener som kemoterapeutiske midler - Google Patents

Bistriazener som kemoterapeutiske midler

Info

Publication number: DK0531419T3
Authority: DK; Denmark
Prior art keywords: compounds; bistriazene; cancer; bistriazenes; chemotherapeutic agents
Prior art date: 1990-05-24

Application number

DK91910672T

Other languages

English (en)

Inventor

Christopher J Michejda

Jeffrey J Blumenstein

Original Assignee

Us Commerce

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-05-24

Filing date

1991-05-22

Publication date

1999-11-29

1991-05-22 Application filed by Us Commerce filed Critical Us Commerce

1999-11-29 Application granted granted Critical

1999-11-29 Publication of DK0531419T3 publication Critical patent/DK0531419T3/da

Links

239000002246 antineoplastic agent Substances 0.000 title 1
229940127089 cytotoxic agent Drugs 0.000 title 1
150000001875 compounds Chemical class 0.000 abstract 4
230000001093 anti-cancer Effects 0.000 abstract 2
206010028980 Neoplasm Diseases 0.000 abstract 1
230000015572 biosynthetic process Effects 0.000 abstract 1
201000011510 cancer Diseases 0.000 abstract 1
239000003431 cross linking reagent Substances 0.000 abstract 1
229920002521 macromolecule Polymers 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
238000003786 synthesis reaction Methods 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C245/00—Compounds containing chains of at least two nitrogen atoms with at least one nitrogen-to-nitrogen multiple bond
- C07C245/22—Compounds containing chains of at least two nitrogen atoms with at least one nitrogen-to-nitrogen multiple bond containing chains of three or more nitrogen atoms with one or more nitrogen-to-nitrogen double bonds
- C07C245/24—Chains of only three nitrogen atoms, e.g. diazoamines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
General Chemical & Material Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

DK91910672T 1990-05-24 1991-05-22 Bistriazener som kemoterapeutiske midler DK0531419T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US52791590A	1990-05-24	1990-05-24
PCT/US1991/003445 WO1991017753A1 (en)	1990-05-24	1991-05-22	Bistriazenes as chemotherapeutic agents

Publications (1)

Publication Number	Publication Date
DK0531419T3 true DK0531419T3 (da)	1999-11-29

Family

ID=24103474

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK91910672T DK0531419T3 (da)	1990-05-24	1991-05-22	Bistriazener som kemoterapeutiske midler

Country Status (10)

Country	Link
US (2)	US5672593A (da)
EP (1)	EP0531419B1 (da)
JP (1)	JPH05506452A (da)
AT (1)	ATE182468T1 (da)
AU (1)	AU642273B2 (da)
CA (1)	CA2083148C (da)
DE (1)	DE69131481T2 (da)
DK (1)	DK0531419T3 (da)
ES (1)	ES2134778T3 (da)
WO (1)	WO1991017753A1 (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5808038A (en) *	1990-05-24	1998-09-15	The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services	Bistriazenes as chemotherapeutic agents
DE69230622T2 (de) *	1991-10-31	2000-07-20	The Government Of The United States Of America As Represented By The Secretary Of National Institute Of Health, Office Of Technology Transfer	Bistriazene als chemotherapeutische wirkstoffe
US5548070A (en) *	1993-07-22	1996-08-20	Wacker-Chemie Gmbh	Organosilicon compounds having triazene groups
DE19508076C2 (de) *	1995-03-08	1998-04-30	Csb Syst Software Entwicklung	Schaltungsanordnung zur Integration eines Sprachsystems in EDV-Systeme und Telefonanlagen, die an das öffentliche Telefonnetz angeschlossen sind
ZA973642B (en) *	1996-04-26	1997-11-25	Merck & Co Inc	DNA vaccine formulations.
US6875907B2 (en)	2000-09-13	2005-04-05	Pioneer Hi-Bred International, Inc.	Antimicrobial peptides and methods of use
WO2003027243A2 (en)	2001-09-27	2003-04-03	Pioneer Hi-Bred International, Inc.	Phytate polynucleotides and methods of use
US7358419B2 (en)	2002-04-08	2008-04-15	Pioneer Hi-Bred International, Inc.	Enhanced silk exsertion under stress
US7987056B2 (en)	2004-09-20	2011-07-26	The Regents Of The University Of Colorado, A Body Corporate	Mixed-library parallel gene mapping quantitative micro-array technique for genome-wide identification of trait conferring genes
KR20160116056A (ko)	2008-08-14	2016-10-06	테바 파마슈티컬즈 오스트레일리아 피티와이 엘티디	항-ｉｌ-12/ｉｌ-23 항체
EP2557075A1 (de)	2011-08-09	2013-02-13	Trin Therapeutics GmbH	Neue Triazenverbindungen zur Behandlung von Krebs
AR088515A1 (es)	2011-10-25	2014-06-18	Pioneer Hi Bred Int	Metodos para alterar la composicion de la pared celular vegetal para obtener produccion de biocombustible y digestibilidad de silaje mejoradas
WO2020121304A1 (en) *	2018-12-10	2020-06-18	Ariel Scientific Innovations Ltd.	Therapeutic conjugates

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3138521A (en) *	1960-10-04	1964-06-23	Gen Aniline & Film Corp	Fungicidal method
CH482789A (de) *	1967-03-16	1969-12-15	Ciba Geigy	Verfahren zur Herstellung neuer Disazofarbstoffpigmente
DE1793115A1 (de) *	1968-08-03	1972-02-03	Bayer Ag	Neue Triazenderivate
DE3426644A1 (de) *	1984-07-19	1986-02-06	Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts, 6900 Heidelberg	N,n-bis((1-aryl-3-methyltriazen-3-yl) methyl)ether
US4923970A (en) *	1988-03-28	1990-05-08	Bionetics Research, Inc.	Substituted 1-(2-chloroethyl)-3-acyl-3-alkyltriazenes

1991
- 1991-05-22 AT AT91910672T patent/ATE182468T1/de not_active IP Right Cessation
- 1991-05-22 ES ES91910672T patent/ES2134778T3/es not_active Expired - Lifetime
- 1991-05-22 WO PCT/US1991/003445 patent/WO1991017753A1/en not_active Ceased
- 1991-05-22 DK DK91910672T patent/DK0531419T3/da active
- 1991-05-22 EP EP91910672A patent/EP0531419B1/en not_active Expired - Lifetime
- 1991-05-22 AU AU80897/91A patent/AU642273B2/en not_active Ceased
- 1991-05-22 JP JP91510441A patent/JPH05506452A/ja active Pending
- 1991-05-22 DE DE69131481T patent/DE69131481T2/de not_active Expired - Fee Related
- 1991-05-22 CA CA002083148A patent/CA2083148C/en not_active Expired - Fee Related
1993
- 1993-06-28 US US08/082,902 patent/US5672593A/en not_active Expired - Fee Related
1995
- 1995-05-31 US US08/455,704 patent/US5731301A/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
EP0531419A1 (en)	1993-03-17
ES2134778T3 (es)	1999-10-16
EP0531419A4 (en)	1994-04-06
EP0531419B1 (en)	1999-07-28
US5672593A (en)	1997-09-30
JPH05506452A (ja)	1993-09-22
DE69131481T2 (de)	1999-11-25
CA2083148A1 (en)	1991-11-25
WO1991017753A1 (en)	1991-11-28
ATE182468T1 (de)	1999-08-15
US5731301A (en)	1998-03-24
AU8089791A (en)	1991-12-10
CA2083148C (en)	2002-01-01
DE69131481D1 (de)	1999-09-02
AU642273B2 (en)	1993-10-14

Similar Documents

Publication	Publication Date	Title
FI980341A0 (fi)	1998-02-13	2-oksi-indolijohdannaisia
FI931031A0 (fi)	1993-03-09	Mometasonfuroatmonohydrat, foerfarande foer dess framstaellning och farmaceutiska sammansaettningar
YU13396A (sh)	1999-06-15	N-(3-benzofuranil) urea derivati, postupci za njihovo dobijanje, kompozicije koje ih sadrže i njihova upotreba u lekovima
KR960004344A (ko)	1996-02-23	6원 질소 함유 헤테로아릴-옥사졸리디논
ATE182468T1 (de)	1999-08-15	Bistriazene als chemotherapeutische mittel
ES502656A0 (es)	1982-11-01	Un procedimiento para la preparacion de nuevos derivados de 2-propanol
ATE45153T1 (de)	1989-08-15	Benzisoselenazolthione, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische produkte.
ATE102604T1 (de)	1994-03-15	Diarylverbindungen als antiatherosklerotische mittel.
PT722319E (pt)	2002-10-31	Derivados de antraciclinona e a sua utilizacao no tratamento da amiloidose
KR960703863A (ko)	1996-08-31	암 치료용 신규 비스-나프탈이미드(New Bis-naphthalimides for the Treatment of Cancer)
UA48958C2 (uk)	2002-09-16	9-o-оксимові похідні еритроміцину а та фармацевтична композиція на їх основі
AU7116781A (en)	1981-12-10	Para-substituted-3-phenoxy-1-alkoxycarbenyl-alkylamino- propanol-2 compounds
SE8405588D0 (sv)	1984-11-08	New compounds
DE69132578D1 (de)	2001-05-10	Cephemderivate
KR880007070A (ko)	1988-08-26	백내장 치료용 약학 조성물
BR9305752A (pt)	1997-01-28	Composto composiçao farmaceutica e processo para a preparaçao de um composto de derivados alquila da trazodona
DK0626943T3 (da)	2000-04-17	Bistriazener som kemoterapimidler
KR890017363A (ko)	1989-12-15	스트로빌루린 유도체, 이들의 제법 및 용도
BR9101973A (pt)	1991-12-24	Compostos quimicos,processo para a sua preparacao e composicoes farmaceutica e terapeutica
NO903291D0 (no)	1990-07-24	Renin-hemmende aminooligohydroksy-derivater.
ATE41774T1 (de)	1989-04-15	(+)-cyanidan-3-ol derivate, verfahren zu deren herstellung und diese verbindungen enthaltende pharmazeutische praeparate und deren verwendung.
ATE47863T1 (de)	1989-11-15	Makrolide derivate.
KR950702942A (ko)	1995-08-23	암의 간전이 억제용 의약 조성물 및 간암 치료용 의약 조성물(pharmaceutical compositions for preventing liver metastasis of cancer and pharmaceutical composition for the treatment of liver cancer)